A special linker between macrophage and hematopoietic malignant cells: Membrane form of macrophage colony-stimulating factor

Cancer Research

Volumn 68, Issue 14, 2008, Pages 5639-5647

  Wang, Lin ^a   Zheng, Guo Guang ^a   Ma, Cui Hua ^a   Lin, Yong Min ^a   Zhang, Hai Yan ^a   Ma, Yuan Yuan ^a   Chong, Jing Hui ^a   Wu, Ke Fu ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLONY STIMULATING FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; SCATTER FACTOR; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LYMPHOMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CELL MEMBRANE; CYTOLOGY; HEMATOPOIETIC SYSTEM; METABOLISM; NUDE MOUSE; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; HEMATOPOIETIC SYSTEM; HEPATOCYTE GROWTH FACTOR; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48649097262     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-5804     Document Type: Article

References (48)

1. Kawasaki ES, Ladner MB, Wang AM, et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor (CSF-1). Science 1985;230:291-6.
2. Cerretti DP, Wignall J, Anderson D, et al. Human macrophage-colony stimulating factor: alternative RNA and protein processing from a single gene. Mol Immunol 1988;25:761-70.
3. Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985;41:665-76.
4. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006;18:39-48.
5. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 2004;14:628-38.
6. Pollard JW. Tumour-educated macrophages promote tumor progression and metastasis. Nat Rev Cancer 2004;4:71-8.
7. Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 1995;27:79-85.
8. Kirma N, Hammes LS, Liu YG, et al. Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-β1 in inducing c-fms expression. Cancer Res 2007;67:1918-26.
9. Mroczko B, Groblewska M, Wereszczyñska-Siemiatkowska U, et al. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 2007;380:208-12.
10. Baiocchi G, Kavanagh JJ, Talpaz M, Wharton JT, Gutterman JU, Kurzrock R. Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies. Cancer 1991;67:990-6.
11. Janowska-Wieczorek A, Belch AR, Jacobs A, et al. Increased circulating colony-stimulating factor-1 in patients with pre-leukemia, leukemia and lymphoid malignancies. Blood 1991;77:1796-803.
12. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
13. Wyckoff J, Wang W, Lin EY, et al. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 2004;64:7022-9.
14. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
15. Crowther M, Brown NJ, Bishop ET, Lewis CE. Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors. J Leukoc Biol 2001;70:478-90.
16. Yano S, Hanibuchi M, Nishioka Y, et al. Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted SCID mice. Int J Cancer 1999;82:105-11.
17. Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW. Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells. Br J Haematol 1993;83:545-53.
18. Moore RN, Oppenheim JJ, Farrar JJ, Carter CS, Jr., Waheed A, Shadduck RK. Production of lymphocyte-activating factor (Interleukin1) by macrophages activated with colony-stimulating factors. J Immunol 1980;125:1302-5.
19. Warren MK, Ralph P. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity. J Immunol 1986;137:2281-5.
20. Heard JM, Roussel MF, Rettenmier CW, Sherr CJ. Synthesis, post-translational processing, and autocrine transforming activity of a carboxylterminal truncated form of colony stimulating factor-1. Oncogene Res 1987;1:423-40.
21. Uemura N, Ozawa K, Takahashi K, et al. Binding of membrane-anchored macrophage colony-stimulating factor (M-CSF) to its receptor mediates specific adhesion between stromal cells and M-CSF receptor-bearing hematopoietic cells. Blood 1993;82:2634-40.
22. Tuck DP, Cerretti DP, Hand A, Guha A, Sorba S, Dainiak N. Human macrophage colony-stimulating factor is expressed at and shed from the cell surface. Blood 1994;84:2182-8.
23. Stein J, Borzillo GV, Rettenmier CW. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood 1990;76:1308-14.
24. Zheng G, Rao Q, Wu K, He Z, Geng Y. Membrane-bound macrophage colony-stimulating factor and its receptor play adhesion molecule-like roles in leukemic cells. Leuk Res 2000;24:375-83.
25. Tsuboi I, Revol V, Blanchet JP, Mouchiroud G. Role of the membrane form of human colony stimulating factor-1 (CSF-1) in proliferation of multipotent hematopoietic FDCP-mix cells expressing human CSF-1 receptor. Leukemia 2000;14:1460-6.
26. Dai XM, Zong XH, Sylvestre V, Stanley ER. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface csf-1. Blood 2004;103:1114-23.
27. Graf MR, Jadus MR, Hiserodt JC, Wepsic HT, Granger GA. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor. J Immunol 1999;163:5544-51.
28. Jadus MR, Chen Y, Boldaji MT, et al. Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins. Cancer Gene Ther 2003;10:411-20.
29. + T-cell immunity against the parental tumor. Mol Ther 2001;4:427-37.
30. Williams CC, Trinh H, Tran TV, et al. Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer. Mol Ther 2001;3:216-24.
31. Wu KF, Rao Q, Zheng GG, et al. Enhancement of J6-1 human leukemicc ell proliferation by membrane bound M-CSF through a cell-cell contact mechanism II: Role of an M-CSF receptor like membrane protein. Leuk Res 1998;22:55-60.
32. Zheng GG, Wu KF, Geng YQ, et al. Expression of membrane-associated macrophage colony-stimulating factor (mM-CSF) in Hodgkin's diseases and other hematologic malignancies. Leuk Lymphoma 1999;32:339-44.
33. Asano T, Kaneko E, Shinozaki S, et al. Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ J 2007;71:405-11.
34. Tominaga K, Saito S, Matsuura M, Funatogawa K, Matsumura H, Nakano M. Role of IFN-γ on dissociation between nitricox ide and TNF/IL-6 production by murine peritoneal cells after restimulation with bacterial lipopolysaccharide. J Leukoc Biol 1999;66:974-80.
35. Albini A, Tosetti F, Benelli R, Noonan DM. Tumor inflammatory angiogenesis and its chemoprevention. Cancer Res 2005;65:10637-41.
36. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9.
37. Lin EY, Li JF, Gnatovskiy L, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006;66:11238-46.
38. Torii S, Yamamoto T, Tsuchiya Y, Nishida E. ERK map kinase in G cell cycle progression and cancer. Cancer Sci 2006;97:697-702.
39. Wang MH, Zheng GG, Wu KF, et al. Co-immunization with M-CSFR and mM-CSF DNA vaccines is better than M-CSFR-mM-CSF fusion DNA vaccine. Haematologica 2002;87:1087-94.
40. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992;3:65-71.
41. Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964-8.
42. Manger R, Najita L, Nichols EJ, Hakomori S, Rohrschneider L. Cell surface expression of the McDonough strain of feline sarcoma virus fms gene product (gp 140fms). Cell 1984;34:327-37.
43. Guilbert LJ, Stanley ER. The interaction of 125I-colony stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem 1986;261:4024-32.
44. Ree HJ, Crowley JP, Leone LA. Macrophage-histiocytes in malignant lymphoma, small lymphocytic type (well-differentiated lymphocytic lymphoma). Cancer 1985;56:1117-23.
45. Ree HJ, Kadin ME. Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophage-histiocytes to clinicopathologic presentation and course of disease. Cancer 1985;56:333-8.
46. Lavie G, Shoenfeld Y, Shaklai M, Aderka D, Pick AI, Pinkhas J. Homogeneous populations of macrophages from histiocytic lymphoma patients as a source for macrophage subpopulations which differ in immunoregulatory properties. Cancer 1982;50:69-77.
47. Iwakiri D, Samanta M, Takada K. Mechanisms of EBV-mediated oncogenesis. Uirusu 2006;56:201-8.
48. Yang W, Wu K, Song Y. Effect of HHV-6 on expression of M-CSF in patients with hematological disorders. Zhong hua Xue Ye Xue Za Zhi 1998;19:646-8.